Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10013776HBVENSG00000004468.13protein_codingCD38NoNo952P28907
TVIS10013777HBVENSG00000004468.13protein_codingCD38NoNo952P28907
TVIS10010803HBVENSG00000004468.13protein_codingCD38NoNo952P28907
TVIS10012513HBVENSG00000004468.13protein_codingCD38NoNo952P28907
TVIS10012614HBVENSG00000004468.13protein_codingCD38NoNo952P28907
TVIS10013270HBVENSG00000004468.13protein_codingCD38NoNo952P28907
TVIS10013469HBVENSG00000004468.13protein_codingCD38NoNo952P28907
TVIS30074261HIVENSG00000004468.13protein_codingCD38NoNo952P28907
TVIS44007007HTLV-1ENSG00000004468.13protein_codingCD38NoNo952P28907
TCGA Plot Options
Drug Information
GeneCD38
DrugBank IDDB09331
Drug NameDaratumumab
Target IDBE0005459
UniProt IDP28907
Regulation Typeantibody
PubMed IDs21187443
Citationsde Weers M, Tai YT, van der Veer MS, Bakker JM, Vink T, Jacobs DC, Oomen LA, Peipp M, Valerius T, Slootstra JW, Mutis T, Bleeker WK, Anderson KC, Lokhorst HM, van de Winkel JG, Parren PW: Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. J Immunol. 2011 Feb 1;186(3):1840-8. doi: 10.4049/jimmunol.1003032. Epub 2010 Dec 27.
GroupsApproved
Direct ClassificationPeptides
SMILES
Pathways
PharmGKB
ChEMBLCHEMBL1743007